Surveillance of Antimicrobial Resistance in Gram-Negative Isolates from Intensive Care Units in Turkey: Analysis of Data from the Last 5 Years
- 1 January 2002
- journal article
- research article
- Published by Taylor & Francis in Journal of Chemotherapy
- Vol. 14 (2) , 140-146
- https://doi.org/10.1179/joc.2002.14.2.140
Abstract
A multicenter antimicrobial surveillance program was established in Turkey in 1995 to monitor the predominant Gram-negative pathogens from intensive care units (ICUs) and antimicrobial resistance patterns of these isolates. Sixteen hospitals participated in the study and a total of 1479 isolates from 1100 patients were collected. The isolates were tested for their susceptibility against 13 antibiotics by E-test method. Minimum inhibitory concentrations (MICs) for each isolate were determined for imipenem, ceftazidime, cef-tazidime-clavulanate, cefoperazone-sulbactam, ceftriaxone, cefepime, cefurox-ime, piperacillin-tazobactam, ticarcillin-clavulanate, gentamicin, amikacin and ciprofloxacin. The most common isolates were Pseudomonas spp. (28.2%), Escherichia coli (19.2%) and Klebsiella spp. (19.1%). We found very high resistance rates to all major antibiotics that are used to treat serious infections. Although imipenem is the most active agent, it had an overall susceptibility rate of 68%. Half of the tested Klebsiella spp. strains were found to produce ESBL. This is a very high rate when compared with the literature. Cross-resistance among species was also investigated. 52% of ciprofloxacin-resistant strains were also resistant to imipenem, 80% to ceftazidime, 97% to ceftriaxone, 86% to amikacin and 19% of imipenem-resistant strains were susceptible to ceftazidime and 18% to amikacin. When susceptibilities of the years 1995 and 1999 were compared, the most interesting finding was the decrease in resistance to 3rd generation cephalosporins. In conclusion, this national clinical isolate database shows that resistance rates are high, the change over years is not predictable and continuous surveillance is necessary to monitor antimicrobial resistance and to guide antibacterial therapy.Keywords
This publication has 12 references indexed in Scilit:
- Surveillance of antimicrobial resistance among Gram-negative isolates from intensive care units in eight hospitals in TurkeyJournal of Antimicrobial Chemotherapy, 2000
- A surveillance study of antimicrobial resistance of Gram-negative bacteria isolated from intensive care units in eight hospitals in TurkeyJournal of Antimicrobial Chemotherapy, 1999
- Antimicrobial susceptibility patterns for pathogens isolated from patients in Latin American medical centers with a diagnosis of pneumonia: analysis of results from the SENTRY Antimicrobial Surveillance Program (1997)Diagnostic Microbiology and Infectious Disease, 1998
- Antimicrobial Activity and Spectrum Investigation of Eight Broad-Spectrum β-Lactam Drugs: A 1997 Surveillance Trial in 102 Medical Centers in the United StatesDiagnostic Microbiology and Infectious Disease, 1998
- Antimicrobial Resistance Rates Among Aerobic Gram-Negative Bacilli Recovered from Patients in Intensive Care Units: Evaluation of a National Postmarketing Surveillance ProgramClinical Infectious Diseases, 1996
- Resistance to extended-spectrum cephalosporins, caused by PER-1 -lactamase, in M Salmonella typhimurium from Istanbul, TurkeyJournal of Medical Microbiology, 1995
- beta-Lactamases in laboratory and clinical resistanceClinical Microbiology Reviews, 1995
- The Prevalence of Nosocomial Infection in Intensive Care Units in EuropeJAMA, 1995
- Transferable production of PER-1 β-lactamase in Pseudomonas aeruginosaJournal of Antimicrobial Chemotherapy, 1995
- Plasmid-Mediated -Lactamase (TEM-7) Involved in Resistance to Ceftazidime and AztreonamClinical Infectious Diseases, 1988